Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Butel

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Annales Pharmaceutiques Francaises|January 12, 2015
[Fecal microbiota transplantation: review]F Barbut, A Collignon, M-J Butel, et al.
The British Journal of Nutrition|June 29, 2002
Oligofructose and experimental model of neonatal necrotising enterocolitisM-J Butel, A-J Waligora-Dupriet, O Szylit
La Revue Du Praticien|May 21, 1991
[Epidemiology and prevention of perinatal group B streptococcal infections]C Lejeune, C Floch, M J Butel, et al.
Systematic and Applied Microbiology|June 18, 2011
Longitudinal analysis and genotyping of infant dominant bifidobacterial populationsJ Aires, M Thouverez, S Allano, et al.
Journal of Developmental Origins of Health and Disease|March 23, 2018
The developing gut microbiota and its consequences for healthM-J Butel, A-J Waligora-Dupriet, S Wydau-Dematteis
Annales De Biologie Clinique|December 13, 2006
[Linezolid: antibacterial activity, clinical efficacy and resistance]N Bourgeois-Nicolaos, O Piriou, M J Butel, et al.
Presse Medicale (Paris, France : 1983)|March 19, 1988
[Indications of antibiotherapy in digestive salmonellosis in newborn infants]M Robin, M J Butel, P Weber, et al.
The Journal of Antimicrobial Chemotherapy|December 3, 2004
Antimicrobial susceptibility of bifidobacteriaC Moubareck, F Gavini, L Vaugien, et al.
Applied and Environmental Microbiology|November 24, 2006
Inhibitory impact of bifidobacteria on the transfer of beta-lactam resistance among Enterobacteriaceae in the gnotobiotic mouse digestive tractC Moubareck, M Lecso, E Pinloche, et al.
Annales Pharmaceutiques Francaises|September 16, 2014
[Why could gut microbiota become a medication?]P Bourlioux, F Megerlin, G Corthier, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Annales Pharmaceutiques Francaises|January 12, 2015
[Fecal microbiota transplantation: review]F Barbut, A Collignon, M-J Butel, et al.
The British Journal of Nutrition|June 29, 2002
Oligofructose and experimental model of neonatal necrotising enterocolitisM-J Butel, A-J Waligora-Dupriet, O Szylit
La Revue Du Praticien|May 21, 1991
[Epidemiology and prevention of perinatal group B streptococcal infections]C Lejeune, C Floch, M J Butel, et al.
Systematic and Applied Microbiology|June 18, 2011
Longitudinal analysis and genotyping of infant dominant bifidobacterial populationsJ Aires, M Thouverez, S Allano, et al.
Journal of Developmental Origins of Health and Disease|March 23, 2018
The developing gut microbiota and its consequences for healthM-J Butel, A-J Waligora-Dupriet, S Wydau-Dematteis
Annales De Biologie Clinique|December 13, 2006
[Linezolid: antibacterial activity, clinical efficacy and resistance]N Bourgeois-Nicolaos, O Piriou, M J Butel, et al.
Presse Medicale (Paris, France : 1983)|March 19, 1988
[Indications of antibiotherapy in digestive salmonellosis in newborn infants]M Robin, M J Butel, P Weber, et al.
The Journal of Antimicrobial Chemotherapy|December 3, 2004
Antimicrobial susceptibility of bifidobacteriaC Moubareck, F Gavini, L Vaugien, et al.
Applied and Environmental Microbiology|November 24, 2006
Inhibitory impact of bifidobacteria on the transfer of beta-lactam resistance among Enterobacteriaceae in the gnotobiotic mouse digestive tractC Moubareck, M Lecso, E Pinloche, et al.
Annales Pharmaceutiques Francaises|September 16, 2014
[Why could gut microbiota become a medication?]P Bourlioux, F Megerlin, G Corthier, et al.
Pageof 4